Biotech · Private company · Charleston, SC, US
Leukogene Therapeutics, Inc.
Track this companyFree. Adds Leukogene Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- AGR2-superantigen vaccine conjugate for the treatment of pancreaticductal adenocarcinomaFiscal year 2025 · $742.9KNIH RePORTER 5R44CA268138-04 · fetched Nov 12, 2026
- AGR2-superantigen vaccine conjugate for the treatment of pancreaticductal adenocarcinomaFiscal year 2024 · $742.9KNIH RePORTER 5R44CA268138-03 · fetched Nov 12, 2026